Your browser doesn't support javascript.
loading
Prophylaxis and Remediation for Future Pandemic Pathogens-(Lessons from a Post-COVID World).
Obrenovich, Mark E; Tayahi, Moncef B; Heidt, Caryn L; Emancipator, Steven N.
Afiliação
  • Obrenovich ME; Department of Veteran's Affairs Medical Center, Research Service, Cleveland, OH 44106, USA.
  • Tayahi MB; Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Heidt CL; The Gilgamesh Foundation for Medical Science and Research, Cleveland, OH 44116, USA.
  • Emancipator SN; Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43614, USA.
Microorganisms ; 10(12)2022 Dec 05.
Article em En | MEDLINE | ID: mdl-36557660
ABSTRACT
Since influenza and coronaviruses are currently deadly and emerging threats worldwide, better treatment, remediation and prevention options are needed. In that regard, a basic understanding of severe acute respiratory syndrome (SARS)-CoV-2/COVID-19 (Betacoronaviridae) and other viral pathogen mechanisms of transmission are expected. Unfortunately, unprecedented, and growing distrust of vaccines and even masks or personal protective equipment (PPE) in the United States and elsewhere presents itself as an added challenge. We postulate that development of improved and highly effective prophylactic measures, together with new life-saving therapies that do inhibit or otherwise treat infection of SARS-CoV-2, influenza and other viral pathogens, could be an adjunct measure to globally protect vulnerable individuals from pandemic threats. In this review, we share what we learned from the past COVID experience to offer a multifactorial and improved approach to current and future pandemic infections or threats using low-cost means.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article